US Physicalrapy Financials

USPH Stock  USD 98.02  0.19  0.19%   
Based on the key measurements obtained from US Physicalrapy's financial statements, US Physicalrapy is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December. As of now, US Physicalrapy's Property Plant And Equipment Net is increasing as compared to previous years. The US Physicalrapy's current Net Debt is estimated to increase to about 111.1 M, while Other Current Liabilities is projected to decrease to under 11.7 M. Key indicators impacting US Physicalrapy's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.470.3821
Fairly Up
Slightly volatile
Current Ratio2.172.2838
Notably Down
Slightly volatile
The essential information of the day-to-day investment outlook for US Physicalrapy includes many different criteria found on its balance sheet. An individual investor should monitor US Physicalrapy's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in US Physicalrapy.

Net Income

15.64 Million

  
Understanding current and past US Physicalrapy Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of US Physicalrapy's financial statements are interrelated, with each one affecting the others. For example, an increase in US Physicalrapy's assets may result in an increase in income on the income statement.

US Physicalrapy Stock Summary

US Physicalrapy competes with Acadia Healthcare, Tenet Healthcare, HCA Holdings, DaVita HealthCare, and InnovAge Holding. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company was founded in 1990 and is based in Houston, Texas. US Physical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 3158 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS90337L1089
CUSIP90337L108
LocationTexas; U.S.A
Business Address1300 West Sam
SectorHealth Care Providers & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.usph.com
Phone713 297 7000
CurrencyUSD - US Dollar

US Physicalrapy Key Financial Ratios

US Physicalrapy Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets560.8M594.4M749.4M858.2M997.2M1.0B
Other Current Liab30.9M26.5M12.5M3.4M18.7M11.7M
Net Debt114.3M78.1M194.5M263.7M105.8M111.1M
Retained Earnings184.4M212.0M223.6M232.9M223.8M235.0M
Accounts Payable2.5M1.3M6.5M6.5M3.9M4.1M
Cash23.5M32.9M28.6M31.6M152.8M160.5M
Net Receivables56.1M41.9M46.3M51.9M51.9M27.3M
Other Current Assets5.8M12.8M20.3M27.7M28.7M30.1M
Total Liab181.4M184.4M297.0M373.6M345M362.3M
Total Current Assets85.4M87.6M95.2M111.3M233.4M245.0M
Short Term Debt27.2M59.9M61.8M75.3M78.2M82.1M
Intangible Assets52.6M56.3M86.4M108.8M109.7M115.2M
Good Will317.7M345.6M434.7M494.1M509.6M484.1M
Common Stock149K150K151K152K172K147.0K
Other Assets1.5M14.1M1.6M1.6M1.9M2.1M
Long Term Debt50.4M16.6M117.6M175.8M139.0M145.9M
Other Liab10.2M12.3M21.7M34.3M39.5M41.5M
Net Tangible Assets7.7M6.6M(225.5M)(287.1M)(258.4M)(245.4M)
Long Term Debt Total38.4M50.4M16.6M117.6M135.2M142.0M

US Physicalrapy Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense2.1M1.6M942K5.8M9.3M9.8M
Total Revenue482.0M423.0M495.0M553.1M604.8M635.0M
Gross Profit112.5M94.5M117.2M112.0M112.0M117.6M
Operating Income67.4M52.4M76.8M56.8M69.6M73.0M
Ebit67.4M67.1M74.1M61.4M58.7M31.5M
Ebitda83.1M77.7M85.7M76.1M74.4M37.7M
Cost Of Revenue369.5M328.5M377.8M441.1M492.8M517.5M
Net Income57.3M52.5M57.9M43.4M14.7M15.6M
Income Tax Expense13.6M13.0M15.3M12.2M12.2M7.7M
Income Before Tax70.9M65.5M73.2M55.6M49.4M31.9M
Minority Interest17.2M17.3M(17.1M)(11.2M)(20.4M)(19.3M)
Interest Income46K142K199K859K3.1M3.2M
Net Interest Income(2.0M)(1.5M)(743K)(4.9M)(6.5M)(6.8M)

US Physicalrapy Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash180K9.4M(4.4M)3.0M121.2M127.3M
Free Cash Flow52.3M92.4M68.2M50.3M72.7M76.3M
Other Non Cash Items(560K)5.7M5.1M10.2M22.3M23.4M
Capital Expenditures10.2M7.6M8.2M8.2M9.3M5.3M
Net Income57.3M52.5M57.9M43.4M37.2M20.1M
End Period Cash Flow23.5M32.9M28.6M31.6M152.8M160.5M
Depreciation10.1M10.5M11.6M14.7M15.7M16.5M
Change To Inventory(742K)4.2M(12.4M)(4.7M)(5.4M)(5.6M)
Dividends Paid14.6M4.1M18.8M21.3M24.1M25.3M
Investments(221K)(111K)427K(81.3M)(80.0M)(76.0M)
Change Receivables(4.5M)(8.9M)2.6M(11.0M)(9.9M)(9.4M)
Net Borrowings6.6M(31.0M)93.1M64.2M73.8M77.5M
Change To Netincome16.6M14.4M35.7M33.1M38.0M39.9M

USPH Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining US Physicalrapy's current stock value. Our valuation model uses many indicators to compare US Physicalrapy value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across US Physicalrapy competition to find correlations between indicators driving US Physicalrapy's intrinsic value. More Info.
US Physicalrapy is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.89  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for US Physicalrapy is roughly  1.12 . As of now, US Physicalrapy's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the US Physicalrapy's earnings, one of the primary drivers of an investment's value.

US Physicalrapy Systematic Risk

US Physicalrapy's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. US Physicalrapy volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on US Physicalrapy correlated with the market. If Beta is less than 0 US Physicalrapy generally moves in the opposite direction as compared to the market. If US Physicalrapy Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one US Physicalrapy is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of US Physicalrapy is generally in the same direction as the market. If Beta > 1 US Physicalrapy moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in US Physicalrapy Stock are looking for potential investment opportunities by analyzing not only static indicators but also various US Physicalrapy's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of US Physicalrapy growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(1.39)

As of now, US Physicalrapy's Price Earnings To Growth Ratio is decreasing as compared to previous years.

US Physicalrapy November 26, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of US Physicalrapy help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of US Physicalrapy. We use our internally-developed statistical techniques to arrive at the intrinsic value of US Physicalrapy based on widely used predictive technical indicators. In general, we focus on analyzing USPH Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build US Physicalrapy's daily price indicators and compare them against related drivers.

Complementary Tools for USPH Stock analysis

When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges